Review




Structured Review

Merck & Co rabbit polyclonal anti-human 2b r
Schematic representation of the design of experiments on cultured enteric glial cells (EGCs). EGCs were treated for three days with palmitate (PA, 400 μM). Then, cells were incubated for 2 h with lipopolysaccharide (LPS, 10 μg/mL) before the addition of adenosine deaminase (ADA, 3 U/mL), to minimize interferences by extracellular adenosine. Under these conditions, cells were treated for 19 h with MRS1754 (0.1 µM, A <t>2B</t> <t>R</t> antagonist) or incubated for 1 h with MRS1754 before the addition of BAY60-6583 (0.05 µM, selective A 2B R agonist, 18 h). For the experiments with the inhibitor of glial cell-derived neurotrophic factor (GDNF) receptor signaling, cells were treated with RPI-1 (100 µM, 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-H-indol-2-one) for 19 h. On the fourth day, cells were lysed for analysis of toll-like receptor 4 (TLR4) expression and the culture media were collected for analysis of substance P (SP), GDNF, and interleukin (IL)-1β release.
Rabbit Polyclonal Anti Human 2b R, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti-human+2b+r/rabbit+polyclonal+anti+human+2b/pmc07290602-62-21-28
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-human 2b r - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity"

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity

Journal: Cells

doi: 10.3390/cells9051245

Schematic representation of the design of experiments on cultured enteric glial cells (EGCs). EGCs were treated for three days with palmitate (PA, 400 μM). Then, cells were incubated for 2 h with lipopolysaccharide (LPS, 10 μg/mL) before the addition of adenosine deaminase (ADA, 3 U/mL), to minimize interferences by extracellular adenosine. Under these conditions, cells were treated for 19 h with MRS1754 (0.1 µM, A 2B R antagonist) or incubated for 1 h with MRS1754 before the addition of BAY60-6583 (0.05 µM, selective A 2B R agonist, 18 h). For the experiments with the inhibitor of glial cell-derived neurotrophic factor (GDNF) receptor signaling, cells were treated with RPI-1 (100 µM, 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-H-indol-2-one) for 19 h. On the fourth day, cells were lysed for analysis of toll-like receptor 4 (TLR4) expression and the culture media were collected for analysis of substance P (SP), GDNF, and interleukin (IL)-1β release.
Figure Legend Snippet: Schematic representation of the design of experiments on cultured enteric glial cells (EGCs). EGCs were treated for three days with palmitate (PA, 400 μM). Then, cells were incubated for 2 h with lipopolysaccharide (LPS, 10 μg/mL) before the addition of adenosine deaminase (ADA, 3 U/mL), to minimize interferences by extracellular adenosine. Under these conditions, cells were treated for 19 h with MRS1754 (0.1 µM, A 2B R antagonist) or incubated for 1 h with MRS1754 before the addition of BAY60-6583 (0.05 µM, selective A 2B R agonist, 18 h). For the experiments with the inhibitor of glial cell-derived neurotrophic factor (GDNF) receptor signaling, cells were treated with RPI-1 (100 µM, 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-H-indol-2-one) for 19 h. On the fourth day, cells were lysed for analysis of toll-like receptor 4 (TLR4) expression and the culture media were collected for analysis of substance P (SP), GDNF, and interleukin (IL)-1β release.

Techniques Used: Cell Culture, Incubation, Derivative Assay, Expressing

( A ) Representative confocal microphotographs showing the distribution of the neural marker HuC/D (yellow), the glial protein S100β (green), and A 2B Rs (magenta) in colonic longitudinal smooth muscle with attached myenteric plexus (LMMP) whole mount preparations from mice fed with standard diet (SD) or high-fat diet (HFD), in the absence or presence of 50 μM fluorocitrate (FC). White arrowheads indicate HuC/D + and A 2B R + neurons, while white stars indicate S100β + and A 2B R + glial cells. Scale bars = 22 μm; analysis of A 2B R ( B ) and S100B ( C ) density index in colonic LMMP whole mount preparations from mice fed with SD or HFD, in the absence or presence of 50 μM FC. * p < 0.05, ** p < 0.01 versus SD without FC; aa p < 0.01 versus HFD; n = 5 mice per group.
Figure Legend Snippet: ( A ) Representative confocal microphotographs showing the distribution of the neural marker HuC/D (yellow), the glial protein S100β (green), and A 2B Rs (magenta) in colonic longitudinal smooth muscle with attached myenteric plexus (LMMP) whole mount preparations from mice fed with standard diet (SD) or high-fat diet (HFD), in the absence or presence of 50 μM fluorocitrate (FC). White arrowheads indicate HuC/D + and A 2B R + neurons, while white stars indicate S100β + and A 2B R + glial cells. Scale bars = 22 μm; analysis of A 2B R ( B ) and S100B ( C ) density index in colonic LMMP whole mount preparations from mice fed with SD or HFD, in the absence or presence of 50 μM FC. * p < 0.05, ** p < 0.01 versus SD without FC; aa p < 0.01 versus HFD; n = 5 mice per group.

Techniques Used: Marker

Schematic representation of the proposed role of A 2B Rs in the modulation of enteric glial cell (EGC) activity under experimental conditions mimicking obesity. In vitro incubation of EGCs with palmitate (PA, 400 μM) and lipopolysaccharide (LPS, 10 μg/mL) elicited an increase in TLR4 expression as well as substance P (SP), glial cell-derived neurotrophic factor (GDNF), and interleukin (IL)-1β release, suggesting an involvement of these cells in supporting the enteric inflammation and abnormal tachykininergic enteric motor responses associated with obesity. The pharmacological stimulation of A 2B Rs on EGCs, besides reducing TLR4 expression and IL-1β levels, can also counteract the abnormal increase in GDNF and SP release. A 2B R: adenosine A 2B receptor; AC: adenylyl cyclase; ATP: adenosine triphosphate; cAMP: cyclic adenosine monophosphate; NF-ҡB: nuclear factor kappa-light-chain-enhancer of activated B cells.
Figure Legend Snippet: Schematic representation of the proposed role of A 2B Rs in the modulation of enteric glial cell (EGC) activity under experimental conditions mimicking obesity. In vitro incubation of EGCs with palmitate (PA, 400 μM) and lipopolysaccharide (LPS, 10 μg/mL) elicited an increase in TLR4 expression as well as substance P (SP), glial cell-derived neurotrophic factor (GDNF), and interleukin (IL)-1β release, suggesting an involvement of these cells in supporting the enteric inflammation and abnormal tachykininergic enteric motor responses associated with obesity. The pharmacological stimulation of A 2B Rs on EGCs, besides reducing TLR4 expression and IL-1β levels, can also counteract the abnormal increase in GDNF and SP release. A 2B R: adenosine A 2B receptor; AC: adenylyl cyclase; ATP: adenosine triphosphate; cAMP: cyclic adenosine monophosphate; NF-ҡB: nuclear factor kappa-light-chain-enhancer of activated B cells.

Techniques Used: Activity Assay, In Vitro, Incubation, Expressing, Derivative Assay

Related Articles

Incubation:

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Cell Culture:

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Derivative Assay:

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Expressing:

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Marker:

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Activity Assay:

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

In Vitro:

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.



Similar Products

90
Merck & Co rabbit polyclonal anti-human 2b r
Schematic representation of the design of experiments on cultured enteric glial cells (EGCs). EGCs were treated for three days with palmitate (PA, 400 μM). Then, cells were incubated for 2 h with lipopolysaccharide (LPS, 10 μg/mL) before the addition of adenosine deaminase (ADA, 3 U/mL), to minimize interferences by extracellular adenosine. Under these conditions, cells were treated for 19 h with MRS1754 (0.1 µM, A <t>2B</t> <t>R</t> antagonist) or incubated for 1 h with MRS1754 before the addition of BAY60-6583 (0.05 µM, selective A 2B R agonist, 18 h). For the experiments with the inhibitor of glial cell-derived neurotrophic factor (GDNF) receptor signaling, cells were treated with RPI-1 (100 µM, 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-H-indol-2-one) for 19 h. On the fourth day, cells were lysed for analysis of toll-like receptor 4 (TLR4) expression and the culture media were collected for analysis of substance P (SP), GDNF, and interleukin (IL)-1β release.
Rabbit Polyclonal Anti Human 2b R, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti-human+2b+r/rabbit+polyclonal+anti+human+2b/pmc07290602-62-21-28
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-human 2b r - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Schematic representation of the design of experiments on cultured enteric glial cells (EGCs). EGCs were treated for three days with palmitate (PA, 400 μM). Then, cells were incubated for 2 h with lipopolysaccharide (LPS, 10 μg/mL) before the addition of adenosine deaminase (ADA, 3 U/mL), to minimize interferences by extracellular adenosine. Under these conditions, cells were treated for 19 h with MRS1754 (0.1 µM, A 2B R antagonist) or incubated for 1 h with MRS1754 before the addition of BAY60-6583 (0.05 µM, selective A 2B R agonist, 18 h). For the experiments with the inhibitor of glial cell-derived neurotrophic factor (GDNF) receptor signaling, cells were treated with RPI-1 (100 µM, 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-H-indol-2-one) for 19 h. On the fourth day, cells were lysed for analysis of toll-like receptor 4 (TLR4) expression and the culture media were collected for analysis of substance P (SP), GDNF, and interleukin (IL)-1β release.

Journal: Cells

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity

doi: 10.3390/cells9051245

Figure Lengend Snippet: Schematic representation of the design of experiments on cultured enteric glial cells (EGCs). EGCs were treated for three days with palmitate (PA, 400 μM). Then, cells were incubated for 2 h with lipopolysaccharide (LPS, 10 μg/mL) before the addition of adenosine deaminase (ADA, 3 U/mL), to minimize interferences by extracellular adenosine. Under these conditions, cells were treated for 19 h with MRS1754 (0.1 µM, A 2B R antagonist) or incubated for 1 h with MRS1754 before the addition of BAY60-6583 (0.05 µM, selective A 2B R agonist, 18 h). For the experiments with the inhibitor of glial cell-derived neurotrophic factor (GDNF) receptor signaling, cells were treated with RPI-1 (100 µM, 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-H-indol-2-one) for 19 h. On the fourth day, cells were lysed for analysis of toll-like receptor 4 (TLR4) expression and the culture media were collected for analysis of substance P (SP), GDNF, and interleukin (IL)-1β release.

Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Techniques: Cell Culture, Incubation, Derivative Assay, Expressing

( A ) Representative confocal microphotographs showing the distribution of the neural marker HuC/D (yellow), the glial protein S100β (green), and A 2B Rs (magenta) in colonic longitudinal smooth muscle with attached myenteric plexus (LMMP) whole mount preparations from mice fed with standard diet (SD) or high-fat diet (HFD), in the absence or presence of 50 μM fluorocitrate (FC). White arrowheads indicate HuC/D + and A 2B R + neurons, while white stars indicate S100β + and A 2B R + glial cells. Scale bars = 22 μm; analysis of A 2B R ( B ) and S100B ( C ) density index in colonic LMMP whole mount preparations from mice fed with SD or HFD, in the absence or presence of 50 μM FC. * p < 0.05, ** p < 0.01 versus SD without FC; aa p < 0.01 versus HFD; n = 5 mice per group.

Journal: Cells

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity

doi: 10.3390/cells9051245

Figure Lengend Snippet: ( A ) Representative confocal microphotographs showing the distribution of the neural marker HuC/D (yellow), the glial protein S100β (green), and A 2B Rs (magenta) in colonic longitudinal smooth muscle with attached myenteric plexus (LMMP) whole mount preparations from mice fed with standard diet (SD) or high-fat diet (HFD), in the absence or presence of 50 μM fluorocitrate (FC). White arrowheads indicate HuC/D + and A 2B R + neurons, while white stars indicate S100β + and A 2B R + glial cells. Scale bars = 22 μm; analysis of A 2B R ( B ) and S100B ( C ) density index in colonic LMMP whole mount preparations from mice fed with SD or HFD, in the absence or presence of 50 μM FC. * p < 0.05, ** p < 0.01 versus SD without FC; aa p < 0.01 versus HFD; n = 5 mice per group.

Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Techniques: Marker

Schematic representation of the proposed role of A 2B Rs in the modulation of enteric glial cell (EGC) activity under experimental conditions mimicking obesity. In vitro incubation of EGCs with palmitate (PA, 400 μM) and lipopolysaccharide (LPS, 10 μg/mL) elicited an increase in TLR4 expression as well as substance P (SP), glial cell-derived neurotrophic factor (GDNF), and interleukin (IL)-1β release, suggesting an involvement of these cells in supporting the enteric inflammation and abnormal tachykininergic enteric motor responses associated with obesity. The pharmacological stimulation of A 2B Rs on EGCs, besides reducing TLR4 expression and IL-1β levels, can also counteract the abnormal increase in GDNF and SP release. A 2B R: adenosine A 2B receptor; AC: adenylyl cyclase; ATP: adenosine triphosphate; cAMP: cyclic adenosine monophosphate; NF-ҡB: nuclear factor kappa-light-chain-enhancer of activated B cells.

Journal: Cells

Article Title: Glial A 2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity

doi: 10.3390/cells9051245

Figure Lengend Snippet: Schematic representation of the proposed role of A 2B Rs in the modulation of enteric glial cell (EGC) activity under experimental conditions mimicking obesity. In vitro incubation of EGCs with palmitate (PA, 400 μM) and lipopolysaccharide (LPS, 10 μg/mL) elicited an increase in TLR4 expression as well as substance P (SP), glial cell-derived neurotrophic factor (GDNF), and interleukin (IL)-1β release, suggesting an involvement of these cells in supporting the enteric inflammation and abnormal tachykininergic enteric motor responses associated with obesity. The pharmacological stimulation of A 2B Rs on EGCs, besides reducing TLR4 expression and IL-1β levels, can also counteract the abnormal increase in GDNF and SP release. A 2B R: adenosine A 2B receptor; AC: adenylyl cyclase; ATP: adenosine triphosphate; cAMP: cyclic adenosine monophosphate; NF-ҡB: nuclear factor kappa-light-chain-enhancer of activated B cells.

Article Snippet: The LMMP preparations were then incubated overnight at room temperature with guinea pig polyclonal anti-rat S100β (1:100; Synaptic Systems, Göttingen, Germany), rabbit polyclonal anti-human A 2B R (1:50; Merck Life Science, Milan, Italy), and mouse biotin-conjugated anti-human-HuC/D (1:100; Thermo Fisher Scientific, Milan, Italy) primary antibodies.

Techniques: Activity Assay, In Vitro, Incubation, Expressing, Derivative Assay